Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.15, Iss.1, 1999-01, pp. : 75-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Benefit Analysis of a Haemophilus Influenzae Type B Meningitis Prevention Programme in The Philippines

By Limcangco M.R.M.T.

PharmacoEconomics, Vol. 19, Iss. 4, 2001-04 ,pp. : 391-400

Adis International

Access to resources Recommend Favorite

Vaccination responses to Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters

By Selander B. Kayhty H. Wedege E. Holmstrom E. Truedsson L. Soderstrom C. Sjoholm A.G.

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 74-74

Elsevier

Access to resources Recommend Favorite

Reactogenicity and Safety of DTPa Vaccine and Haemophilus influenzae Type b Conjugate Vaccine (Hib) in a Single Injection vs DTPw and Hib as Separate Injections as a Booster Vaccination in 18-Month-Old Children

By Arístegui J.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 9-16

Adis International

Access to resources Recommend Favorite

Cost-Benefit Analysis of Amtolmetin-Guacil

By Belisari A. Mantovani L.G.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 47-58

Adis International

Access to resources Recommend Favorite

Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops

By Desjeux Guillaume

PharmacoEconomics, Vol. 23, Iss. 9, 2005-01 ,pp. : 913-926

Adis International

Access to resources Recommend Favorite